Skip to main content

Table 1 Comparison of fatty acid compositions in healthy persons and patients (%, X ± S)

From: Changes in erythrocyte polyunsaturated fatty acids and plasma eicosanoids level in patients with asthma

 

Healthy group (n = 31)

Patients group (n = 31)

C14:0

0.30 ± 0.25

0.65 ± 0.48**

C15:0

0.10 ± 0.04

0.17 ± 0.09

C15:1

2.43 ± 0.46

1.95 ± 0.44**

C16:0

17.76 ± 0.83

19.74 ± 2.12**

C16:1

0.26 ± 0.12

0.51 ± 0.17**

C18:0

10.26 ± 0.60

10.43 ± 0.69

C18:1

12.14 ± 1.23

14.02 ± 1.96**

C18:2(n-6)

10.69 ± 1.24

10.47 ± 1.99

C18:3(n-3)

0.07 ± 0.02

0.09 ± 0.07

C20:0

0.32 ± 0.05

0.34 ± 0.10

C20:1

0.25 ± 0.05

0.27 ± 0.08

C20:2(n-6)

0.79 ± 0.46

0.30 ± 0.13**

C20:3(n-6)

1.37 ± 0.30

1.45 ± 0.32

C20:4(n-6)

16.52 ± 1.07

15.52 ± 2.12*

C20:5(n-3)

0.64 ± 0.35

0.73 ± 0.41

C22:0

4.86 ± 1.93

4.16 ± 2.74

C22:4(n-6)

2.96 ± 0.54

2.76 ± 0.80

C22:5(n-3)

2.25 ± 0.40

2.18 ± 0.48

C22:6(n-3)

7.57 ± 1.52

4.55 ± 1.87**

C24:0

4.24 ± 1.03

6.21 ± 1.55*

C24:1

4.21 ± 0.70

3.51 ± 1.12**

n-6

32.33 ± 1.57

30.49 ± 3.03**

n-3

10.52 ± 2.05

7.56 ± 2.37**

n-6/n-3

3.21 ± 0.79

4.42 ± 1.33*

AA

16.52

15.52

EPA + DHA

8.21

5.28

AA/(EPA + DHA)

2.01

2.94

SFA

37.84

41.70

MUFA

19.29

20.26

PUFA

42.86

38.05

UFA

62.15

58.31

SFA/UFA

0.61

0.72

  1. Note: *, p < 0.05; **, p < 0.01